Iovance Biotherapeutics, Inc. (IOVA)

Everbridge Revenue

Iovance Biotherapeutics had revenue of $49.32M in the quarter ending March 31, 2025, with 6,798.46% growth. This brings the company's revenue in the last twelve months to $212.68M, up 11,070.12% year-over-year. In the year 2024, Iovance Biotherapeutics had annual revenue of $164.07M with 13,698.99% growth.

• Revenue (ttm): $212.68M
• Revenue Growth: +11,070.12%
• P/S Ratio: 4.05
• Revenue / Employee: $253,794
• Employees: 838
• Market Cap: 945.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.